Linopirdine

This classification denotes a cation channel blocker with the molecular formula C26H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) I5TB3NZ94T, chemically known as 1,3-dihydro-1-phenyl-3,3-bis(4-pyridinylmethyl)-2h-indol-2-one but more generally known as linopirdine, which bears US NIH Compound Identifier 3932. European Medicines Agency schedules Linopirdine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08522MIG. The term LINOPIRDINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 7, No3, 1993, List 33). World Health Organization schedules linopirdine in its Anatomical Therapeutic Chemical (ATC) Classification. LINOPIRDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule linopirdine under HS 29337900 and SITC 51561. As of Q4 2014, LINOPIRDINE remains US FDA's Preferred Term for this commodity. Linopirdine bears US NLM identifiers UMLS ID C0286263 and NCI Concept Code C82306. SMILES: O=C1N(C2C(C1(CC1CCNCC1)CC1CCNCC1)CCCC2)C1CCCCC1.